Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
The first phase of the special interest group (SIG) on hospital pharmacist’s preparedness for in-vivo gene therapy medicinal products (GTMP) closed its work in April 2023. Since then, the SIG has been working on finalising the report that was published on 16 June.
This report presents the findings of the special interest group on hospital pharmacist’s preparedness for GTMP. This SIG was financially supported by Pfizer and set up by the European Association of Hospital Pharmacists (EAHP).
The SIG carried out desk research and a survey to gather information on the hospital pharmacy preparedness for gene therapy medicines throughout Europe and on preparing and optimising multidisciplinary care teams for the integration of gene therapy medicines into the treatment tools for patients with rare diseases.
The report includes a proposal for future training activities on GTMP for hospital pharmacists and identifies the need for an update of the EAHP Guidance for Handling GTMP published in 2007. The SIG is currently working on the update on the guidance.
EAHP’s General Assembly designates Nenad Miljković as President-Elect and welcomes Cyprus as a full member
From 8 to 10 June, the members of the European Association of Hospital Pharmacists (EAHP) gathered in Krakow, Poland for their 53rd General Assembly to discuss the evolving role of the hospital pharmacist and the future development of the Association.
EAHP is delighted to announce that Dr Nenad Miljković has been elected as the next President of EAHP, commencing a 3 year term of office in June 2024. He will now serve as President-Elect during the final year of András Süle’s presidency. Dr Miljković is the Head of the Hospital Pharmacy Services at the Institute of Orthopaedics Banjica in Belgrade, Serbia. He obtained his PhD degree in Clinical Pharmacy at the University of Belgrade in 2021 for health risk assessment in medicine shortages in cooperation with KU Leuven. In addition to his pharmacy degree with …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.